The first robotic transanal minimally invasive surgery in Ireland:  a case‑based review by Hannan, Enda et al.
Vol.:(0123456789) 
Irish Journal of Medical Science (1971 -) 
https://doi.org/10.1007/s11845-021-02645-9
CASE BASED REVIEWS
The first robotic transanal minimally invasive surgery in Ireland: 
a case‑based review
Enda Hannan1  · Gerard Feeney1 · Mohammad Fahad Ullah1 · Kamran Amin1 · John Calvin Coffey1,2 · Colin Peirce1,2
Received: 21 March 2021 / Accepted: 6 May 2021 
© The Author(s) 2021
Abstract
Transanal minimally invasive surgery (TAMIS) has gained worldwide acceptance as a means of local excision of early rectal 
cancers and benign rectal lesions. However, it is technically challenging due to the limitations of rigid laparoscopic instru-
ments in the narrow rectal lumen. Robotic platforms offer improved ergonomics that are valuable in operative fields with 
limited space. Robotic TAMIS represents an exciting new development that may be more versatile than traditional TAMIS. 
In this review, we describe the first case of robotic TAMIS performed in our country and a review of current literature on 
the technique.
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Abbreviations
TME  Total mesorectal excision
TAE  Transanal excision
TEMS  Transanal endoscopic microsurgery
TAMIS  Transanal minimally invasive surgery
L-TAMIS  Laparoscopic transanal minimally invasive 
surgery
R-TAMIS  Robotic transanal minimally invasive surgery
TVA  Tubulovillous adenoma
HGD  High grade dysplasia
MRI  Magnetic resonance imaging
CT  Computed tomography
MDM  Multidisciplinary meeting
Introduction
Due to morbidity associated with total mesorectal excision 
(TME), transanal approaches have been developed to treat 
early-stage rectal cancers and benign lesions [1]. However, 
conventional transanal excision (TAE) using anoscopic 
instrumentation is challenging due to inadequate exposure 
and visibility within the rectal lumen, compromising the 
ability to obtain adequate oncologic resection [2]. Transa-
nal endoscopic microsurgery (TEMS) was first described by 
Buess in 1983 to overcome these challenges and uses pneu-
morectum, an operative microscope and angulated instru-
ments to perform full-thickness excision of rectal lesions [1, 
2]. This has been shown to significantly improve oncological 
outcomes and specimen quality compared with TAE, while 
also allowing access to more proximal lesions [3]. Despite 
this, adoption of TEMS in clinical practice has been lim-
ited [2, 3]. This is due to a steep learning curve, availability 
of costly specialised instrumentation and limited training 
opportunities in this technique [3]. TEMS is also not feasible 
for lesions close to the anal verge [3].
Transanal minimally invasive surgery (TAMIS) was intro-
duced as an evolution of TEMS, whereby traditional laparo-
scopic instruments are inserted via a multi-access transanal 
port to perform local excision [3, 4]. This technique has 
gained worldwide popularity, providing the same quality 
of resection as TEMS without the cost and steep learning 
curve [3, 4]. However, TAMIS is not without limitations. 
Laparoscopic instruments are limited by their rigid design 
and inability to fully articulate. These restrictions become 
more pronounced when operating in small spaces such as the 
rectal lumen, where clashing of instruments and restrictive 
working angles act as barriers to performing safe dissection 
[4].
Robotic surgical platforms were developed to over-
come the limitations of laparoscopic surgery by offering 
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a stable 3-dimensional view, improved ergonomics and 
greater range of motion [4, 5]. Robotic surgery has 
proven to be particularly beneficial in areas with limited 
space, such as the pelvis and mediastinum [5]. Robotic 
TAMIS (R-TAMIS) was described to address the short-
comings of laparoscopic TAMIS (L-TAMIS) and has 
since been reported favourably in case reports and small 
case series [5]. However, R-TAMIS remains a novel pro-
cedure that is only performed in a small number of spe-
cialised centres [1–5]. In this report, we describe our first 
experience with R-TAMIS. To our knowledge, this is the 
first such case performed in Ireland.
Case presentation
A 45-year-old female with no significant medical history 
attended for an urgent colonoscopy to investigate rectal 
bleeding. This demonstrated a sessile polyp with a diam-
eter of 4 cm located posteriorly at the second rectal valve 
approximately 8 cm from the anal verge (Fig. 1). A par-
tial polypectomy was performed, and the specimen was 
sent for histological analysis, which reported a tubulovil-
lous adenoma (TVA) with high grade dysplasia (HGD) 
and features suspicious for malignancy. Staging magnetic 
resonance imaging (MRI) of the pelvis noted a mid-rectal 
lesion suspicious for T1 or possibly T2 invasion without 
mesorectal lymphadenopathy. Computed tomography 
(CT) of the thorax, abdomen and pelvis did not detect 
potential metastatic disease. Following discussion at the 
gastrointestinal multidisciplinary meeting (MDM) and 
consultation with the patient the decision to proceed 
R-TAMIS using the da Vinci® Xi dual console robotic 
surgical system (Intuitive Surgical Inc, Sunnyvale, CA, 
USA) was made.
The patient was fully informed of the risks and benefits of 
this approach, including the potential necessity to proceed to 
an anterior resection with total mesorectal excision (TME) 
should the final histological result deem this necessary. The 
patient was also made aware that this would represent the 
first time this procedure had been performed in our coun-
try, and that the option of an anterior resection was also 
available. Following this, the patient opted to proceed with 
R-TAMIS. The procedure was performed by a fellowship-
trained consultant colorectal surgeon on the specialist divi-
sion of the medical register who had completed a proctorship 
programme in robotic colorectal surgery and achieved certi-
fication with the European Association of Robotic Colorec-
tal Surgery [6]. The surgeon had also performed the required 
number of cases for competency in L-TAMIS [1].
After completion of mechanical bowel preparation, 
the procedure was commenced under general anaes-
thetic with the patient in the lithotomy position so 
that the lesion would be seen at the 6 o’clock position 
intraoperatively. Three robotic arms were utilised via 
8-mm robotic trocars placed into the GelPOINT™ Path 
Transanal Access Platform (Applied Medical Inc., Ran-
cho Santa Margarita, CA, USA), which was inserted into 
the anal canal and suture anchored to the surrounding 
skin. The robot system was docked from the left side 
of the patient. The first robotic arm held a fenestrated 
grasper with bipolar diathermy, the second the robotic 
camera and the third a curved scissors with monopolar 
diathermy. A further assistant port, an 8-mm AirSeal® 
trocar (CONMED, Largo, FL, USA) was used to provide 
suction, irrigation, traction and to aid with specimen 
extraction. Pneumorectum of 15 mmHg was established.
After visualisation of the lesion, electrocautery was 
used to mark adequate excision margins circumferen-
tially (Fig. 2). Full-thickness excision of the lesion was 
performed, ensuring not to handle the lesion directly 
and risk fragmentation of the specimen. The presence 
of mesorectal fat in the base of the wound confirmed 
a full-thickness rectal excision. Haemostasis was care-
fully maintained throughout the procedure. For repair of 
the defect, the monopolar scissors were replaced with a 
robotic needle holder, and a 3.0 V-Loc™ barbed absorb-
able suture was inserted via the assistant port which was 
then mounted on the robotic needle holder. The suture 
was placed at the proximal apex of the wound and subse-
quently locked by placing the needle through the loop at 
the end of the thread and securing the resulting knot. The 
remainder of the defect was then repaired transversely 
Fig. 1  Sessile polyp located posteriorly 8 cm from the anal verge at 
the second rectal valve
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in a continuous fashion. Following this, the lumen was 
assessed to ensure patency and that no stenosis had 
occurred (Fig. 3). The specimen was then placed in the 
GELPOINT path port, the robot undocked and the speci-
men retrieved following removal of the GELPOINT path 
seal and sent for histopathological analysis. Intraopera-
tive blood loss was minimal.
The patient had an uneventful recovery and was discharged 
the day after surgery. The final histopathological diagnosis was 
a pT1 invasive moderately differentiated adenocarcinoma aris-
ing in a TVA with HGD with clear lateral margins, a deep 
margin of 6 mm and no poor prognostic features. At postop-
erative discussion at the gastrointestinal MDM, a consensus 
was reached that no further treatment was required given the 
favourable histological features of the excised lesion. The 
patient remains well at routine follow-up and is undergoing 
standard postoperative surveillance for rectal cancer.
Discussion
This report presents the first experience with R-TAMIS in 
our institution, a tertiary referral university teaching hos-
pital. To our knowledge, this represents the first time that 
such a technique has been performed in our country. This 
is of significant importance, as it offers a novel approach to 
early-stage rectal malignancy and benign rectal neoplasms 
that was previously unavailable to our patients. R-TAMIS 
serves as an evolution of traditional L-TAMIS, with the 
characteristics of the robotic platform allowing the sur-
geon to perform more intricate surgery with greater ease 
within the restrictions of the narrow rectal lumen which 
cannot be achieved by rigid laparoscopic instruments [1–5, 
7]. The EndoWrist™ movement allows for improved intra-
luminal dexterity which, combined with a magnified 3D 
view, empowers the surgeon to perform transanal excision 
with improved precision [1, 2, 5]. The surgeon’s ability 
to perform intraluminal suturing is also improved com-
pared to L-TAMIS, where closure of the defect can be 
challenging and time-consuming [3, 5]. These advantages 
offered by the robotic platform may allow lesions that 
previously would have been considered too challenging 
for L-TAMIS to be considered for a transanal approach, 
allowing the patient to avoid the considerable risk of mor-
bidity and mortality associated with an anterior resection 
for a lesion that can be treated curatively by local excision 
[3]. Our results for this first experience with R-TAMIS are 
promising, and we are strongly encouraged by this initial 
outcome.
The literature on R-TAMIS remains relatively sparse, 
and this report provides valuable evidence that further 
serves to validate the technique. However, the evidence 
that currently exists is strongly encouraging [1–5, 7]. The 
technique was first demonstrated by Atallah in 2011 in a 
cadaveric model, a surgeon who is very well renowned in 
this field having described L-TAMIS in 2009 [1]. With rec-
ognition of the limitations of the laparoscopic approach, 
two tasks were assessed, the full-thickness excision of 
rectal tissue and subsequent closure of the defect. This 
was successfully completed in all attempts, and it was con-
cluded that R-TAMIS is safe, feasible and effective. Atal-
lah subsequently performed the first R-TAMIS in a patient 
successfully, which further validated the technique [2].
Following this, Lee et  al. retrospectively compared 
short-term outcomes of 21 patients managed by L-TAMIS 
with those of 19 that underwent R-TAMIS, demonstrat-
ing a high success rate in both cohorts with comparable 
outcomes [3]. Interestingly, blood loss was less in the 
R-TAMIS group, although the cost of surgery was greater. 
A wider range in duration of surgery in the L-TAMIS 
group was attributed to variability of body habitus and 
Fig. 2  Circumferential marking of resection margins
Fig. 3  Assessing luminal patency post suturing of the defect
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tumour location, which can limit L-TAMIS compared to 
the more versatile R-TAMIS. The authors concluded that 
R-TAMIS may facilitate transanal resection not feasible by 
laparoscopic approach [3]. A similarly positive experience 
was observed in a multicentre retrospective study, where 
34 patients over 2 years had rectal lesions ranging from 
2 to 15 cm from the anal verge that were up to 4.5 cm 
in diameter successfully resected with no intraoperative 
complications, with all investigating surgeons reporting 
that R-TAMIS was less technically challenging and had 
a faster learning curve than L-TAMIS [4]. Hompes et al., 
using a surgical glove as an access platform, also reported 
success with R-TAMIS in a series of 16 patients, reporting 
a median hospital stay of 1.3 days and a low rate of mor-
bidity, with one patient developing a pneumoperitoneum 
that was managed conservatively and one patient requir-
ing catheterization for urinary retention [7]. The largest 
reported series of R-TAMIS to date showed the technique 
to be safe in 58 patients with comparable perioperative 
and oncological outcomes to L-TAMIS, noting an advan-
tage of R-TAMIS is the ability to rotate the operative field 
allowing the surgeon to operate on all walls of the rectum 
rather than a single quadrant, thus allowing the surgeon to 
address larger lesions in multiple quadrants [5]. Warren 
et al., in a technical description, reported that a particular 
advantage of R-TAMIS is that the stability of the robotic 
platform creates a clearer view that allows more precise 
dissection, particularly at the upper part of the lesion 
which is usually difficult to visualize in L-TAMIS [8].
The most frequent criticisms of robotic surgery are those 
of increased cost and a longer operating time compared to 
laparoscopic approaches as a result of the expense of acquir-
ing and utilizing robotic surgical systems and the learning 
curve associated with robotic docking [4, 5]. The current 
literature reports that the additional cost of R-TAMIS com-
pared to L-TAMIS is approximately €1000 per procedure 
[6]. This is not insignificant, but may be justified by the 
ergonomic advantages offered by robotic systems allowing 
safer and more efficient removal of rectal lesions [1–5, 7, 8]. 
The cost should also be considered in the context of lesions 
that may not be feasible for L-TAMIS, where the enhanced 
capabilities of R-TAMIS may allow patients to avoid a cost-
lier and potentially much more morbid anterior resection and 
the increased inpatient length of stay associated with this 
[3, 5]. With regards to operating time, the well-recognised 
longer time spent in theatre in robotic operations compared 
to laparoscopic operations has not been replicated in the 
literature with regards to TAMIS. In the only comparative 
study, no significant difference was seen between L-TAMIS 
and R-TAMIS [3]. This is likely as a result of the improved 
intraluminal dexterity compared to L-TAMIS, which makes 
up for time lost in the process of setting up and docking the 
robot [3, 9].
In our case, a T1 cancer was treated by the R-TAMIS 
technique. While TME remains the gold standard curative 
treatment for rectal cancer, it is associated with significant 
risk of morbidity and debilitating effects on anorectal and 
urogenital function [10]. Such factors have prompted the 
need to individualise care and to consider if organ-preserv-
ing approaches may be appropriate [10]. In the USA and 
Europe, full-thickness local excision is indicated for T1N0 
rectal cancers with low-risk pathological features [10]. 
The main concern regarding local excision is the potential 
under-treatment of T1 cancers that are lymph node-positive. 
However, it has been shown that the overall rate of nodal 
metastases in T1 rectal cancers is as low as 6% if there are no 
adverse features present [10]. It has also been demonstrated 
that local excision of T1 lesions does not impact cancer-
specific survival compared to radical resection with TME 
[10]. For these reasons, TAMIS is now widely accepted 
as an appropriate therapy for carefully selected T1 rectal 
cancers[10]
In conclusion, we report our first experience of a patient 
with early-stage rectal cancer successfully managed by 
R-TAMIS. The greater versatility of the robotic platform 
may allow lesions that would be considered unsuitable for 
L-TAMIS to be managed by local excision. Thus, R-TAMIS 
is an important evolution in transanal surgery which serves 
to allow patients to avoid the risks associated with more 
radical resection in early-stage rectal cancers and benign 
lesions.
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